These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 14683453

  • 21. The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.
    Gómez CE, Nájera JL, Krupa M, Esteban M.
    Curr Gene Ther; 2008 Apr; 8(2):97-120. PubMed ID: 18393831
    [Abstract] [Full Text] [Related]

  • 22. Smallpox: can we still learn from the journey to eradication?
    Smith KA.
    Indian J Med Res; 2013 May; 137(5):895-9. PubMed ID: 23760373
    [Abstract] [Full Text] [Related]

  • 23. Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.
    Conrad SJ, Liu J.
    Methods Mol Biol; 2019 May; 1937():189-209. PubMed ID: 30706397
    [Abstract] [Full Text] [Related]

  • 24. Gene therapy with poxvirus vectors.
    Moroziewicz D, Kaufman HL.
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [Abstract] [Full Text] [Related]

  • 25. Poxviruses and the evolution of host range and virulence.
    Haller SL, Peng C, McFadden G, Rothenburg S.
    Infect Genet Evol; 2014 Jan; 21():15-40. PubMed ID: 24161410
    [Abstract] [Full Text] [Related]

  • 26. Poxvirus cancer therapy.
    Gilbert PA, McFadden G.
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):309-21. PubMed ID: 18221156
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis.
    Nichols DB, De Martini W, Cottrell J.
    Viruses; 2017 Aug 08; 9(8):. PubMed ID: 28786952
    [Abstract] [Full Text] [Related]

  • 31. A Genome-Wide Haploid Genetic Screen Identifies Heparan Sulfate-Associated Genes and the Macropinocytosis Modulator TMED10 as Factors Supporting Vaccinia Virus Infection.
    Luteijn RD, van Diemen F, Blomen VA, Boer IGJ, Manikam Sadasivam S, van Kuppevelt TH, Drexler I, Brummelkamp TR, Lebbink RJ, Wiertz EJ.
    J Virol; 2019 Jul 01; 93(13):. PubMed ID: 30996093
    [Abstract] [Full Text] [Related]

  • 32. Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.
    Hu Y, Lee J, McCart JA, Xu H, Moss B, Alexander HR, Bartlett DL.
    J Virol; 2001 Nov 01; 75(21):10300-8. PubMed ID: 11581398
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enhancing poxvirus vectors vaccine immunogenicity.
    García-Arriaza J, Esteban M.
    Hum Vaccin Immunother; 2014 Nov 01; 10(8):2235-44. PubMed ID: 25424927
    [Abstract] [Full Text] [Related]

  • 35. Poxviruses as expression vectors.
    Carroll MW, Moss B.
    Curr Opin Biotechnol; 1997 Oct 01; 8(5):573-7. PubMed ID: 9353230
    [Abstract] [Full Text] [Related]

  • 36. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.
    Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E, Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE.
    Vaccine; 2000 Oct 15; 19(4-5):483-91. PubMed ID: 11027812
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.